-+ 0.00%
-+ 0.00%
-+ 0.00%

BiomX Published Article Titled "Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial" In Nature Communications

Benzinga·07/08/2025 12:36:09
Listen to the news

Premier research journal article provides validation for BiomX's phage therapy platform, showcasing first-in-human Phase 1b/2a trial results for antibiotic-resistant P. aeruginosa infections



New, updated data demonstrates a further bacteria reduction of 2.7 log₁₀ (approximately 500-fold) compared to placebo, with no emergent resistance and preservation of a healthy microbiome



BiomX is advancing its Phase 2b trial of BX004 with topline results expected Q1 2026